Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review

IG Schoots, N Petrides, F Giganti, LP Bokhorst… - European urology, 2015 - Elsevier
Context There is great interest in using magnetic resonance imaging (MRI) for men on active
surveillance for prostate cancer. Objective To systematically review evidence regarding the …

The current state of MR imaging–targeted biopsy techniques for detection of prostate cancer

S Verma, PL Choyke, SC Eberhardt, A Oto… - Radiology, 2017 - pubs.rsna.org
Systematic transrectal ultrasonography (US)–guided biopsy is the standard approach for
histopathologic diagnosis of prostate cancer. However, this technique has multiple …

PI-RADS prostate imaging–reporting and data system: 2015, version 2

JC Weinreb, JO Barentsz, PL Choyke, F Cornud… - European urology, 2016 - Elsevier
Abstract The Prostate Imaging–Reporting and Data System Version 2 (PI-RADS™ v2) is the
product of an international collaboration of the American College of Radiology (ACR) …

Interobserver reproducibility of the PI-RADS version 2 lexicon: a multicenter study of six experienced prostate radiologists

AB Rosenkrantz, LA Ginocchio, D Cornfeld… - Radiology, 2016 - pubs.rsna.org
Purpose To determine the interobserver reproducibility of the Prostate Imaging Reporting
and Data System (PI-RADS) version 2 lexicon. Materials and Methods This retrospective …

A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment

LP Bokhorst, R Valdagni, A Rannikko, Y Kakehi… - European urology, 2016 - Elsevier
Abstract Background The Prostate Cancer Research International Active Surveillance
(PRIAS) study was initiated a decade ago to study the most optimal selection and follow-up …

Proposed adjustments to PI-RADS version 2 decision rules: impact on prostate cancer detection

AB Rosenkrantz, JS Babb, SS Taneja, JM Ream - Radiology, 2017 - pubs.rsna.org
Purpose To test the impact of existing Prostate Imaging Reporting and Data System (PI-
RADS) version 2 (V2) decision rules, as well as of proposed adjustments to these decision …

Prostate cancer: PI-RADS version 2 helps preoperatively predict clinically significant cancers

SY Park, DC Jung, YT Oh, NH Cho, YD Choi, KH Rha… - Radiology, 2016 - pubs.rsna.org
Purpose To retrospectively analyze whether Prostate Imaging Reporting and Data System
(PI-RADS) version 2 is helpful for the detection of clinically significant prostate cancer …

Transperineal versus transrectal MRI/TRUS fusion targeted biopsy: detection rate of clinically significant prostate cancer

P Pepe, A Garufi, G Priolo, M Pennisi - Clinical genitourinary cancer, 2017 - Elsevier
Introduction To evaluate the detection rate for clinically significant prostate cancer (PCa) of
transperineal (TP) versus transrectal (TR) multiparametric (mp) magnetic resonance imaging …

Targeted prostate biopsy to select men for active surveillance: do the Epstein criteria still apply?

JC Hu, E Chang, S Natarajan, DJ Margolis… - The Journal of …, 2014 - auajournals.org
Purpose: Established in 1994, the Epstein histological criteria (Gleason score 6 or less, 2 or
fewer cores positive and 50% or less of any core) have been widely used to select men for …

Magnetic resonance imaging–ultrasound fusion biopsy during prostate cancer active surveillance

GN Tran, MS Leapman, HG Nguyen, JE Cowan… - European Urology, 2017 - Elsevier
Background Fusion biopsy using multiparametric magnetic resonance imaging (MRI) and
transrectal ultrasound has demonstrated favorable detection rates of high-grade prostate …